Breaking News Instant updates and real-time market news.

VEEV

Veeva

$159.50

2.46 (1.57%)

16:10
11/26/19
11/26
16:10
11/26/19
16:10

Veeva raises FY20 adj. EPS view to $2.16-$2.17 from $2.11-$2.13

Consensus $2.12. Raises FY20 revenue view to $1.088B-$1.091B from $1.062B-$1.065B, consensus $1.07B.

  • 26

    Nov

VEEV Veeva
$159.50

2.46 (1.57%)

09/26/19
RAJA
09/26/19
UPGRADE
Target $180
RAJA
Outperform
Veeva pullback offers 'attractive' entry point, says Raymond James
Raymond James analyst Brian Peterson upgraded Veeva Systems to Outperform from Market Perform with a $180 price target ahead of the company's analyst day next week. The recent pullback provides an attractive entry point into the shares, Peterson tells investors in a research note. Specifically, Peterson says he expects management to provide incremental detail on key growth areas including EDC and efforts outside of life sciences, which could be reaching an inflection point, and says that with each of these emerging growth opportunities equating to a $1B+ TAM, this should give investors increasing confidence in the durability of Veeva's growth profile.
10/03/19
WBLR
10/03/19
NO CHANGE
WBLR
Outperform
Veeva introduced 'bullish' 2025 sales target of $3B, says William Blair
William Blair analyst Bhavan Suri says Veeva Systems management yesterday introduced "bullish" long-term targets, including a $3B revenue run-rate goal by calendar 2025, indicating 19% annual growth, largely reflective of growth within life sciences offerings. Increased "agility and speed to market capabilities," as well as the continued adoption of Veeva's early stage products, will lead to "multiple years" of greater than 20% revenue growth with "best-in-class" operating margins in excess of 35%, Suri tells investors in a research note. He reiterates an Outperform rating on the shares.
10/03/19
GUGG
10/03/19
NO CHANGE
GUGG
Buy
Veeva right to invest, but first reaction likely negative, says Guggenheim
After Veeva CFO Tim Cabral announced a new long-term goal of 19% revenue CAGR through 2025 to $3B and a 2025 target for 35%+ EBIT margins at the company's investor day meeting, Guggenheim analyst Ken Wong said he expects the initial investor reaction to the new 5-year targets to be mildly negative and for skeptics to "zero in" on the margins target being seen as a step down from the 38% levels projected for FY20. However, Wong said the growth targets are better than he expected, thinks the margins view feels "conservative" and expects any negativity to be short lived. The analyst, who views the company's elevated investments as appropriate given Veeva's product roadmap, keeps a Buy rating on the stock.
10/03/19
SPHN
10/03/19
NO CHANGE
Target $185
SPHN
Overweight
Veeva leaving room for investments or M&A with 2025 targets, says Stephens
Stephens analyst James Rutherford said some investors may have expected a more aggressive margin outlook than the five-year 35%+ adjusted EBIT margins guidance that Veeva announced yesterday at its investor day, but he believes the company is leaving itself room to make incremental investments and/or pursue additional strategic M&A that could help it achieve its $3B annual revenue target more quickly. Rutherford, who continues to see Veeva as one of the best positioned companies in its industry, keeps an Overweight rating and $185 price target on the shares.

TODAY'S FREE FLY STORIES

CERN

Cerner

$71.81

0.35 (0.49%)

09:02
12/13/19
12/13
09:02
12/13/19
09:02
Hot Stocks
Cerner board of directors authorizes additional $1.5B share repurchase »

Cerner announced that its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIRI

Sirius XM

$6.88

0.01 (0.15%)

09:01
12/13/19
12/13
09:01
12/13/19
09:01
Hot Stocks
Sirius XM announces exclusive radio broadcast agreement with Rolling Loud »

SiriusXM announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNAP

Snap

$14.45

0.22 (1.55%)

, SRPT

Sarepta

$100.39

-1.15 (-1.13%)

09:01
12/13/19
12/13
09:01
12/13/19
09:01
Hot Stocks
Fly Intel: Pre-market Movers »

UP AFTER EARNINGS: Adobe…

SNAP

Snap

$14.45

0.22 (1.55%)

SRPT

Sarepta

$100.39

-1.15 (-1.13%)

ADBE

Adobe

$305.76

2.01 (0.66%)

ORCL

Oracle

$56.47

0.16 (0.28%)

XPER

Xperi

$19.91

0.44 (2.26%)

EXEL

Exelixis

$17.68

0.05 (0.28%)

AVGO

Broadcom

$327.39

7.53 (2.35%)

ANIX

Anixa Biosciences

$3.82

-0.05 (-1.29%)

PTEN

Patterson-UTI

$10.38

0.29 (2.87%)

AQST

Aquestive Therapeutics

$6.73

-0.97 (-12.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Jan

  • 23

    Jan

  • 06

    Feb

  • 13

    Dec

DHR

Danaher

$151.34

1.58 (1.06%)

, GE

General Electric

$11.44

0.46 (4.19%)

08:55
12/13/19
12/13
08:55
12/13/19
08:55
Options
Notable open interest changes for December 13th »

Thursday's total…

DHR

Danaher

$151.34

1.58 (1.06%)

GE

General Electric

$11.44

0.46 (4.19%)

AMD

AMD

$42.61

3.16 (8.01%)

NVST

Envista

$28.47

0.29 (1.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Jan

LULU

Lululemon

$224.48

-8.83 (-3.78%)

08:52
12/13/19
12/13
08:52
12/13/19
08:52
Recommendations
Lululemon analyst commentary  »

Lululemon price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

08:51
12/13/19
12/13
08:51
12/13/19
08:51
Conference/Events
Credit Suisse economists/strategists to hold an analyst/industry conference call »

Economists and…

TREE

LendingTree

$293.67

-13 (-4.24%)

08:51
12/13/19
12/13
08:51
12/13/19
08:51
Recommendations
LendingTree analyst commentary  »

Stephens says LendingTree…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SBGI

Sinclair Broadcast

$30.95

-0.77 (-2.43%)

08:50
12/13/19
12/13
08:50
12/13/19
08:50
Initiation
Sinclair Broadcast initiated  »

Sinclair Broadcast…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEVI

Levi Strauss

$18.41

0.39 (2.16%)

08:49
12/13/19
12/13
08:49
12/13/19
08:49
Recommendations
Levi Strauss analyst commentary  »

Levi Strauss price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTI

Universal Technical

$6.98

-0.27 (-3.72%)

08:48
12/13/19
12/13
08:48
12/13/19
08:48
Syndicate
Universal Technical 3.6M share Spot Secondary priced at $6.25 »

B. Riley FBR acted as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVGO

Broadcom

$327.39

7.53 (2.35%)

08:46
12/13/19
12/13
08:46
12/13/19
08:46
Recommendations
Broadcom analyst commentary  »

Broadcom price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:45
12/13/19
12/13
08:45
12/13/19
08:45
General news
U.S. import prices increased 0.2% »

U.S. import prices…

AMC

AMC Entertainment

$8.29

0.12 (1.47%)

, SCO

Scor ADR

$13.01

-0.21 (-1.59%)

08:45
12/13/19
12/13
08:45
12/13/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

AMC

AMC Entertainment

$8.29

0.12 (1.47%)

SCO

Scor ADR

$13.01

-0.21 (-1.59%)

PLCE

Children's Place

$58.26

4.46 (8.29%)

CHWY

Chewy

$27.95

1.08 (4.02%)

TLRY

Tilray

$18.87

0.68 (3.74%)

BLDP

Ballard Power

$6.17

0.095 (1.56%)

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$12.68

0.11 (0.88%)

GTT

GTT Communications

$12.01

-0.36 (-2.91%)

Z

Zillow

$42.51

-0.22 (-0.51%)

SVXY

ProShares Short VIX Short-Term Futures

$63.16

1.65 (2.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Dec

08:45
12/13/19
12/13
08:45
12/13/19
08:45
General news
U.S. retail sales increased 0.2% in November, and were up 0.1% excluding autos »

U.S. retail sales…

08:45
12/13/19
12/13
08:45
12/13/19
08:45
General news
FX Action: The dollar »

FX Action: The dollar…

VCTR

Victory Capital

$21.68

0.235 (1.10%)

08:44
12/13/19
12/13
08:44
12/13/19
08:44
Downgrade
Victory Capital rating change  »

Victory Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRBP

Corbus Pharmaceuticals

$5.08

0.16 (3.25%)

08:43
12/13/19
12/13
08:43
12/13/19
08:43
Conference/Events
Corbus Pharmaceuticals to hold a webinar »

Expert panel discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

EV

Eaton Vance

$47.08

0.395 (0.85%)

08:42
12/13/19
12/13
08:42
12/13/19
08:42
Upgrade
Eaton Vance rating change  »

Eaton Vance upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TTMI

TTM Technologies

$13.79

0.19 (1.40%)

08:41
12/13/19
12/13
08:41
12/13/19
08:41
Upgrade
TTM Technologies rating change  »

JPMorgan upgrades TTM…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AJG

Arthur J. Gallagher

$94.63

0.16 (0.17%)

08:39
12/13/19
12/13
08:39
12/13/19
08:39
Conference/Events
Arthur J. Gallagher to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

NEWR

New Relic

$66.87

0.86 (1.30%)

08:38
12/13/19
12/13
08:38
12/13/19
08:38
Recommendations
New Relic analyst commentary  »

Morgan Stanley came way…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMK

AssetMark Financial

$27.31

0.42 (1.56%)

08:38
12/13/19
12/13
08:38
12/13/19
08:38
Upgrade
AssetMark Financial rating change  »

JPMorgan upgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LII

Lennox

$259.14

0.71 (0.27%)

08:38
12/13/19
12/13
08:38
12/13/19
08:38
Conference/Events
Lennox to host investor meeting »

Investor meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

VIAC

ViacomCBS

$37.79

0.52 (1.40%)

08:36
12/13/19
12/13
08:36
12/13/19
08:36
Initiation
ViacomCBS initiated  »

ViacomCBS reinstated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLRB

Cellectar Biosciences

$2.23

0.12 (5.69%)

08:35
12/13/19
12/13
08:35
12/13/19
08:35
Hot Stocks
Cellectar Biosciences presents data on CLR 2000045 at AACR symposium »

Cellectar Biosciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.